RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis
Authors:
Open Access
- 6 October 2016
- journal article
- research article
- Published by Springer Nature in Cell Death & Disease
- Vol. 7 (10) , e2402
Abstract
Dysfunction of nuclear factor-κB (NF-κB) signaling has been causally associated with numerous human malignancies. Although the NF-κB family of genes has been implicated in endometrial carcinogenesis, information regarding the involvement of central regulators of NF-κB signaling in human endometrial cancer (EC) is limited. Here, we investigated the specific roles of canonical and noncanonical NF-κB signaling in endometrial tumorigenesis. We found that NF-κB RelB protein, but not RelA, displayed high expression in EC samples and cell lines, with predominant elevation in endometrioid adenocarcinoma (EEC). Moreover, tumor cell-intrinsic RelB was responsible for the abundant levels of c-Myc, cyclin D1, Bcl-2 and Bcl-xL, which are key regulators of cell cycle transition, apoptosis and proliferation in EEC. In contrast, p27 expression was enhanced by RelB depletion. Thus, increased RelB in human EC is associated with enhanced EEC cell growth, leading to endometrial cell tumorigenicity. Our results reveal that regulatory RelB in noncanonical NF-κB signaling may serve as a therapeutic target to block EC initiation.Keywords
This publication has 24 references indexed in Scilit:
- LRG1 is an independent prognostic factor for endometrial carcinomaTumor Biology, 2014
- Control of RelB during dendritic cell activation integrates canonical and noncanonical NF-κB pathwaysNature Immunology, 2012
- The diverse and complex roles of NF-κB subunits in cancerNature Reviews Cancer, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cellsOncogene, 2004
- The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor-κB in HepG2 CellsEndocrinology, 2000
- The Role of CBP in Estrogen Receptor Cross-Talk with Nuclear Factor- B in HepG2 CellsEndocrinology, 2000
- DNA Damaging Agents Induce Expression of Fas Ligand and Subsequent Apoptosis in T Lymphocytes via the Activation of NF-κB and AP-1Molecular Cell, 1998
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983